1. Home
  2. EPIX vs INLX Comparison

EPIX vs INLX Comparison

Compare EPIX & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • INLX
  • Stock Information
  • Founded
  • EPIX 2009
  • INLX 1996
  • Country
  • EPIX Canada
  • INLX United States
  • Employees
  • EPIX N/A
  • INLX 199
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • INLX EDP Services
  • Sector
  • EPIX Health Care
  • INLX Technology
  • Exchange
  • EPIX Nasdaq
  • INLX Nasdaq
  • Market Cap
  • EPIX 73.5M
  • INLX 59.0M
  • IPO Year
  • EPIX N/A
  • INLX N/A
  • Fundamental
  • Price
  • EPIX $1.62
  • INLX $13.95
  • Analyst Decision
  • EPIX Hold
  • INLX
  • Analyst Count
  • EPIX 3
  • INLX 0
  • Target Price
  • EPIX $2.00
  • INLX N/A
  • AVG Volume (30 Days)
  • EPIX 286.3K
  • INLX 4.3K
  • Earning Date
  • EPIX 02-11-2025
  • INLX 11-13-2024
  • Dividend Yield
  • EPIX N/A
  • INLX N/A
  • EPS Growth
  • EPIX N/A
  • INLX N/A
  • EPS
  • EPIX N/A
  • INLX N/A
  • Revenue
  • EPIX N/A
  • INLX $17,930,991.00
  • Revenue This Year
  • EPIX N/A
  • INLX $9.27
  • Revenue Next Year
  • EPIX N/A
  • INLX $8.10
  • P/E Ratio
  • EPIX N/A
  • INLX N/A
  • Revenue Growth
  • EPIX N/A
  • INLX 7.17
  • 52 Week Low
  • EPIX $1.40
  • INLX $4.52
  • 52 Week High
  • EPIX $11.67
  • INLX $16.50
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 25.75
  • INLX 49.53
  • Support Level
  • EPIX $1.63
  • INLX $13.49
  • Resistance Level
  • EPIX $1.74
  • INLX $14.38
  • Average True Range (ATR)
  • EPIX 0.06
  • INLX 0.57
  • MACD
  • EPIX 0.10
  • INLX -0.07
  • Stochastic Oscillator
  • EPIX 12.82
  • INLX 47.96

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document strategy to convert documents from one medium to another.

Share on Social Networks: